Truist reiterates Buy on Inventiva stock ahead of phase 3 data

🌐 Investing.com (Cyprus) —
Truist reiterates Buy on Inventiva stock ahead of phase 3 data

AI Summary

Truist reiterated a Buy rating on Inventiva ahead of the company's phase 3 data. The report provides no further information about the trial or its expected results.

Markets Health Inventiva Truist Buy rating phase 3 clinical data biotechnology

Read original source →